(Q77833662)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10355575%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Double-blind, randomised, placebo-controlled, dose-finding study of oral ibandronate in patients with metastatic bone disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10355575%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

1 reference

R E Coleman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10355575%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

O P Purohit

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10355575%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

C Black

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10355575%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

J J Vinholes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10355575%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

K Schlosser

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10355575%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

H Huss

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10355575%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

K J Quinn

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10355575%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

J Kanis

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10355575%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 March 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10355575%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10355575%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10355575%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10355575%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

311-316

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10355575%20AND%20SRC:MED&resulttype=core&format=json

Treatment of malignancy-associated hypercalcemia with intravenous aminohydroxypropylidene diphosphonate

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386501738

7 January 2021

Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386501738

7 January 2021

A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386501738

7 January 2021

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386501738

7 January 2021

Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386501738

7 January 2021

A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386501738

7 January 2021

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386501738

7 January 2021

A randomised phase II study of oral pamidronate for the treatment of bone metastases from breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386501738

7 January 2021

Esophagitis associated with the use of alendronate

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386501738

7 January 2021

BM 21.0955, a potent new bisphosphonate to inhibit bone resorption

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386501738

7 January 2021

Metabolic effects of pamidronate in patients with metastatic bone disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386501738

7 January 2021

Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386501738

7 January 2021

A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386501738

7 January 2021

Biochemical prediction of response of bone metastases to treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386501738

7 January 2021

Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386501738

7 January 2021

Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386501738

7 January 2021

Relationships between biochemical and symptomatic response in a double-blind randomised trial of pamidronate for metastatic bone disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386501738

7 January 2021

A double-blind, crossover trial of intravenous clodronate in metastatic bone pain

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386501738

7 January 2021

Effect of oral clodronate on metastatic bone pain: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386501738

7 January 2021

Identifiers

DOI

10.1023/A:1008386501738

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10355575%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference